Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-06 Sale | 2022-06-13 4:31 pm | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer 10% Owner | 320,000 | $0.02097 | $6,710 | 23,149,029 (Direct) | View |
| 2022-05-26 Sale | 2022-06-02 5:23 pm | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer 10% Owner | 180,000 | $0.02694 | $4,850 | 23,879,029 (Direct) | View |
| 2022-01-05 Sale | 2022-01-07 5:22 pm | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer 10% Owner | 250,000 | $0.04876 | $12,189 | 24,059,029 (Indirect) | View |
| 2019-11-27 Sale | 2019-12-03 3:47 pm | Kannalife Inc | KLFE | PETKANAS DEAN Chief Executive Officer 10% Owner | 100,000 | $1 | $100,000 | 22,091,721 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-13 Gift | 2022-06-13 4:31 pm | N/A N/A | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer 10% Owner | 400,000 | $0.0161 | 23,149,029 (Direct) | View |
| 2022-01-07 Gift | 2022-01-07 5:22 pm | N/A N/A | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer 10% Owner | 550,000 | $0 | 24,059,029 (Indirect) | View |
| 2021-07-29 Option Award | 2021-08-02 08:04 am | N/A N/A | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer 10% Owner | 1,875,000 | $0.048 | 24,859,029 (Indirect) | View |
| 2021-03-12 Option Award(A) | 2021-03-18 7:08 pm | N/A 2031-03-11 | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer | 1,450,000 | $0 | 24,434,029 (Direct) | View |
| 2021-03-12 Option Award(A) | 2021-03-18 7:08 pm | N/A N/A | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer | 692,308 | $0.13 | 24,434,029 (Indirect) | View |
| 2021-03-12 Option Award | 2021-03-16 4:47 pm | N/A 2031-03-11 | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer | 1,450,000 | $0 | 25,044,432 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-16 4:47 pm | N/A N/A | NEUROPATHIX INC. | NPTX | PETKANAS DEAN Chief Executive Officer | 884,616 | $0.13 | 25,044,432 (Indirect) | View |
| 2020-05-04 Option Award | 2020-05-06 9:46 pm | N/A 2030-05-03 | Kannalife Inc | KLFE | PETKANAS DEAN Chief Executive Officer 10% Owner | 1,450,000 | $0 | 1,450,000 (Direct) | View |
| 2019-08-14 Option Award | 2020-05-06 9:39 pm | N/A N/A | Kannalife Inc | KLFE | PETKANAS DEAN Chief Executive Officer 10% Owner | 200,000 | $0.1 | 22,291,721 (Indirect) | View |